Clinical Evaluation of NG271 on Chronic Urticaria
慢性じん麻疹に対するNG271の臨床試験成績

Tetsuro SUGAI, Junko KATO, Atsuko KUWANO, Masamitsu ISHII, Hiromi KOBAYASHI, Shoji TANIGUCHI, Noriko YASHIRO, Hiroyuki TERAMAE, Takeshi NAKANISHI, Daisuke TSURUTA, Yasushi GOTOH, Akiko HIRAI (+4 others)
1997 Skin Research  
Clinical evaluation of a new granule, NG271, containing 120mg/g of terfenadine was performed in 63 patients with chronic urticaria in an open clinical study. NG271 was given twice a day for 7 days, and was assessed for the improvements of itching and urti caria. The following results were obtained. (1) The improvement rating of itching and urticaria indicated 63.8% and 59.3% in the "Remarkable" and "Moderate" , respectively. (2) The final global improvement rating indicated 65.5% in the
more » ... ble" and 皮 膚 ・第39巻 ・第3号 ・1997年6月 -363-"Moderate" . (3) The overall safety rating indicated 83.3% in the "Safe". (4) The global usefulness rating indicated 62.7% in the "Extremely useful" and "Useful". (5) Incidence of adverse drug reaction was 14.5%, and in none of the cases were serious adverse events observed.
doi:10.11340/skinresearch1959.39.355 fatcat:r5vf7lhp4rephpepnug26phyxy